Stocks to Watch Tomorrow Oct 21: SPCX, TSLA, META & 7 More

The best stocks to watch tomorrow come from a Tuesday session that turned into an earnings rotation: the Dow jumped about 530 points while the Nasdaq finished flat, and then three after-hours reports reshuffled the board. SpaceX posted a blowout third quarter, Super Micro raised its outlook by $4 billion, and Netflix and Intuitive Surgical fell despite earnings beats. On Wednesday, Oct. 21, the spotlight turns to Meta and Tesla after the close. Below are ten stocks to watch tomorrow, from megacaps to micro-caps, each with full data, levels, a bull and bear case and a forecast.

Today’s Market Snapshot: A Broad Rotation Out of Megacap Tech

Index / AssetTuesday, Oct. 20 CloseChange
S&P 5007,712.57+0.28%
Dow Jones Industrial Average52,495.88+1.02% (+529.85 points)
Nasdaq Composite26,424.82-0.02%
Russell 20002,773.42+1.65%
Philadelphia Semiconductor Index11,283.81-0.29%
Crude oil (WTI)About $96About -2.4%

The Dow led as 3M rose almost 6% on a guidance raise, and NYSE advancers beat decliners 1,614 to 559. 24/7 Wall St. described money moving from tech into value and healthcare, and crude fell after an unconfirmed report of a possible U.S.-Iran middle-ground deal.

Macro drivers for Wednesday:

  • Earnings: Meta and Tesla report after the close, alongside IBM, Lam Research and Texas Instruments. AT&T, Abbott, NextEra, Danaher, Thermo Fisher, Philip Morris and Elevance report before the open.
  • Rates and Fed: The Fed is in its quiet period ahead of its Oct. 27-28 meeting after back-to-back hot inflation reports. See TNN’s October Fed rate hike explainer.
  • Geopolitics and deficit: Benzinga flagged Iranian threats to undersea cables and a $1.99 trillion fiscal-2026 deficit.

Data note: Closes are Oct. 20 official prints from StockAnalysis, Yahoo Finance, Finviz, Benzinga or MarketBeat where stated. After-hours prices move quickly, so we show ranges. Netcapital’s and Inovio’s closes and Chaince’s price are derived or intraday and labeled as such. Support and resistance levels are analytical zones, not guarantees. “n/v” means not verified.

1. SpaceX (SPCX) | Blowout Q3 After the Bell | Closed $147.79 (-0.11%)

161% Revenue Growth, a First Real Profit and a $1.9 Trillion Valuation Test

Catalyst & latest news: SpaceX reported revenue of $14.58 billion versus about $12.7 billion expected and adjusted EPS of $0.35 versus roughly $0.11 to $0.15. Its Super Intelligence unit contributed $7.6 billion, up from $813 million a year ago, and ABC reported the AI unit swung to positive operating income. Capex came in below fears after Q2’s $18.4B bill, and the stock rose 1.5% to 5% after hours.

Technicals: SPCX closed at $147.79 on 89.4M shares versus a 94.5M average, per the Motley Fool, and is down about 8% since its June IPO. Options had priced roughly an 8% move.

Fundamentals: Connectivity revenue was $5.2B against $4.9B expected, net income reached $4.4B and the company ended Q3 with 1.7 gigawatts of compute capacity. TNN covered the spectrum angle in its Oct. 12 SpaceX report.

MetricData
Last close / prior close$147.79 (-$0.17, -0.11%) / about $147.96
After-hoursAbout $150 – $155 (+1.5% to +5.2%)
Day’s range / 52-week rangen/v / n/v (IPO June 12; first-day close $161)
Market capAbout $1.9T (derived)
P/E / Dividendn/v / None
Volume vs. average89.4M vs. 94.5M (-5.5%)
PerformanceAbout -8% since IPO
Q3 revenue / EPS$14.58B (+161%) vs. $12.7B est. / $0.35 vs. $0.11 – $0.15 est.
SegmentsSuper Intelligence $7.6B (vs. $6.3B est.); Connectivity $5.2B (vs. $4.9B est.)
Analystsn/v
Support (S1 / S2 / S3)$140 / $135 / $125.33
Resistance (R1 / R2 / R3)$155.40 / $161 / $170

Scenarios: Bullish: a gap above $155 targets the $161 IPO-day close. Base: a gap-and-fade between $147 and $155. Bearish: a failed gap and loss of $140 revisits $135.

Bull case: First solid profit, 161% growth and lower-than-feared capex. Bear case: A roughly $1.9T valuation, heavy AI capex and a stock still below its IPO-week levels.

What to watch:

  • Whether after-hours gains hold at the open
  • Capex and compute-capacity guidance on the call
  • Read-through to Tesla, Rocket Lab and AST SpaceMobile

Forecast: Holding $147 into the open keeps $155 to $161 in play. A fade below $140 would erase the beat.

Why this matters: SpaceX is the market’s biggest new AI-infrastructure proxy, and this report shows whether AI revenue can turn profitable at scale.

2. Super Micro Computer (SMCI) | $4 Billion Guidance Raise | Closed $32.47 (+1.15%)

From $15 Billion to $19 Billion in One Press Release

Catalyst & latest news: Super Micro raised its fiscal first-quarter revenue outlook to $18.5 billion to $19.5 billion, versus a prior $14.5B to $15.5B and a consensus near $15B, and lifted its gross margin range to 12.0% to 12.5%. Bloomberg noted analysts had expected about $15B. Shares jumped roughly 12% to 15% after hours to the mid-$30s.

Technicals: SMCI closed at $32.47 on 26.4M shares after a $30.92 to $33.17 range. It had fallen about 18% in the week to Oct. 15 and sits well below its $56.60 high.

Fundamentals: Fiscal 2026 revenue was $39.06B (+77.8%) and earnings $2.20B. Trailing P/E is about 10.3 and forward P/E about 7.4, with a beta of 2.13. Full results come Nov. 3.

MetricData
Last close / prior close$32.47 (+$0.37, +1.15%) / $32.10
Day’s range$30.92 – $33.17
After-hoursAbout $36.4 – $37.5 (+12% to +15%)
52-week range$19.48 – $56.60
Market capAbout $21.3B
P/E (TTM / forward) / Dividend10.3 / 7.4 / None
Volume vs. average26.4M vs. about 33M (10-day)
Beta2.13
Revenue / earnings (FY2026)$39.06B (+77.8%) / $2.20B (+109%)
Prelim. Q1 FY27Revenue $18.5B – $19.5B (about +280% YoY); gross margin 12.0% – 12.5%
AnalystsHold (18); average target $42.27; Rosenblatt $51; Citi $45; Mizuho $43
Next earningsNov. 3
Support (S1 / S2 / S3)$32.10 / $30.92 / $28
Resistance (R1 / R2 / R3)$35.09 / $37.51 / $42.27

Scenarios: Bullish: a hold above $35 on volume targets $37.5 and then the $42 average target. Base: a pop-and-fade between $33 and $37. Bearish: the gap fills and $30.92 breaks.

Bull case: A giant revenue beat, higher margins and a forward P/E near 7. Bear case: A thin 12% margin, a Hold consensus and a history of accounting and governance concerns.

What to watch:

  • Volume at the open versus its 33M average
  • Dell, HPE and Nvidia read-through
  • Margin commentary before Nov. 3

Forecast: Holding $35.09 points to $37.51. A fade below $32.10 would fully reverse the pop.

Why this matters: The guidance suggests AI server demand is reaccelerating just as chip stocks wobbled, a useful counterpoint for Nvidia and Micron.

3. Netflix (NFLX) | Beat, Then a Guidance Cut | Closed $68.69 (-1.66%)

Down 25% This Year and Sliding Below Its 52-Week Low After Hours

Catalyst & latest news: Netflix earned $0.87 a share versus $0.82 expected on $12.87 billion in revenue, up 12% and in line. The stock fell 4% to 6% after hours because it cut its 2026 advertising forecast to $2.7B from $3B and guided Q4 revenue growth of 12%. Netflix is also cutting about 1,000 jobs, or 6% of staff.

Technicals: NFLX closed at $68.69 on a regular-session loss of 1.7% and traded near $64.7 after hours, below its $65.08 52-week low. It dropped 7.3% on its Q2 report.

Fundamentals: Operating income rose 37% to $4.58B on a 34.6% margin versus a 33.2% forecast. Full-year 2026 revenue is projected at $51.1B, and advertising revenue growth is above 80%.

MetricData
Last close / prior close$68.69 (-$1.16, -1.66%) / $69.85
After-hoursAbout $64.7 (-5.8%)
52-week range$65.08 – $124.86
Market cap / P/En/v / n/v
DividendNone
Volume vs. averagen/v
PerformanceYTD about -25%
Q3 EPS / revenue$0.87 vs. $0.82 est. / $12.87B (+12%), in line
Q4 guidanceRevenue about $13.4B (+12%); EPS about $0.67 (below consensus)
AnalystsBuy-leaning; average target implies about 31% upside
Support (S1 / S2 / S3)$64.62 / $60 / $55
Resistance (R1 / R2 / R3)$68.69 / $69.85 / $75

Scenarios: Bullish: a reclaim of $68.69 on a buyback-supported bounce. Base: a gap down to $64 to $66 and basing. Bearish: a break of $64.62 opens $60.

Bull case: A 34.6% margin, strong ad growth and a depressed multiple. Bear case: The slowest growth in three years, a lowered ad outlook and layoffs.

What to watch:

  • The open versus the $65.08 52-week low
  • Analyst target cuts on Wednesday
  • Disney and Warner read-through

Forecast: Holding $64.62 keeps a bounce toward $68 to $70 plausible. A close under it points to $60.

Why this matters: Netflix shows how a beat is no longer enough when revenue growth slows, a warning for every growth stock reporting this week.

4. Tesla (TSLA) | Earnings After the Bell | Closed $373.71 (+1.54%)

A 346x P/E, a 6.2% Implied Move and a Stock Down 16% This Year

Catalyst & latest news: Tesla reports Q3 on Oct. 21 after the close, and Electrek’s preview shows consensus for flat revenue near $28.1B and EPS of about $0.45, down 10% from a year ago. Options imply a 6.24% move. Q3 deliveries of 486,532 beat estimates of about 461,000, but the stock fell 15.6% after Q2’s EPS miss.

Technicals: TSLA gained 1.5% on a $363.64 to $375.45 range and traded at $378.72 after hours. Investing.com notes a 30-day implied volatility of 43% and a daily ATR near $12.

Fundamentals: Q2 operating margin fell to 1.4% and EPS was $0.33 versus $0.53 expected. Trailing revenue is $103.62B, net income $3.81B and forward P/E near 241x, so any miss leaves little cushion.

MetricData
Last close / prior close$373.71 (+$5.65, +1.54%) / $368.06
Day’s range$363.64 – $375.45
After-hours$378.72 (+1.34%)
52-week range$297.38 – $498.83
Market capAbout $1.48T
P/E (TTM) / DividendAbout 346 / None
Volume vs. averageAbout 19.7M mid-session (full day n/v) vs. about 34.6M 30-day
PerformanceYTD about -16%; 1-year about -16.5%
Beta1.92
Revenue / net income (TTM)$103.62B / $3.81B
Q3 estimatesEPS about $0.45; revenue about $27.9B – $28.1B
AnalystsBuy (44); average target $397.83 (+6.5%); Cantor $485; JPMorgan, Morgan Stanley, Barclays, UBS Hold
Next earningsOct. 21 after close (implied move 6.24%)
Support (S1 / S2 / S3)$363.64 / $350 / $320
Resistance (R1 / R2 / R3)$375.45 / $385 / $397.83

Scenarios: Bullish: a margin beat and autonomy or robotaxi updates push through $385. Base: a 5% to 7% move either way. Bearish: a second EPS miss breaks $350.

Bull case: A delivery beat, AI and autonomy optionality and a Street target above the price. Bear case: Flat revenue, shrinking EPS and a valuation that needs a narrative to hold.

What to watch:

  • Automotive gross margin ex-credits
  • Capex guidance and any SpaceX-related commentary
  • Energy storage margins near the low-20% range

Forecast: A beat targets $385 to $398. A miss likely tests $350.

Why this matters: Tesla is the second half of the week’s mega-cap test, and its reaction will set the tone for consumer AI and autos.

5. Meta Platforms (META) | Earnings After the Bell | Closed $694.25 (-1.59%)

A 10% Pullback Into the Print, and a $130 Billion Capex Question

Catalyst & latest news: Meta reports Q3 on Oct. 21 after the close with a call at 4:30 p.m. ET. Consensus is about $6.58 a share on roughly $63.3B of revenue, up about 23%, and options imply a 5.9% move. Investors want proof that 2026 capex of $130B to $145B is earning a return, since Q2 free cash flow was only $784M.

Technicals: META fell 1.6% on a $681.05 to $696.51 range and 14.0M shares, about 35% below its 21.5M average. MarketBeat notes the pullback of roughly 10% from the Oct. 13 high of $771.27.

Fundamentals: Meta’s year-ago EPS of $1.05 included a $15.93B tax charge, so reported growth will look huge. Bernstein reiterated Buy with an $800 target, Cantor holds $840 and Loop Capital $955.

MetricData
Last close / prior close$694.25 (-$11.19, -1.59%) / $705.44
Day’s range$681.05 – $696.51
After-hours$695.00 (+0.11%)
52-week range$520.26 – $779.82
Market capAbout $1.77T
P/E (TTM) / Dividend26.1 / $2.10 a year (0.30%)
Volume vs. average14.0M vs. 21.5M (30-day)
PerformanceYTD about +5.4% (from a $658.40 year-end)
Beta1.19
Q3 estimatesEPS about $6.58 (vs. $1.05); revenue about $63.3B (+23%)
AnalystsStrong Buy / Moderate Buy; average target $811 – $815; range $580 – $1,050
Next earningsOct. 21 after close (implied move 5.9%)
Support (S1 / S2 / S3)$681.05 / $658.40 / $645.50
Resistance (R1 / R2 / R3)$705.44 / $718.67 / $736.72

Scenarios: Bullish: a revenue beat with steady capex reclaims $718. Base: a 5% to 7% move. Bearish: a capex raise breaks $681 and tests $658.

Bull case: Strong ad growth, early Muse AI traction and a mid-20s multiple. Bear case: Heavy capex, thin free cash flow and the market’s recent sensitivity to AI spending.

What to watch:

  • 2026 and 2027 capex guidance
  • Ad pricing and impressions growth
  • Any update on AI debt or financing

Forecast: A clean print targets $718 to $737. A capex surprise likely tests $658.

Why this matters: Meta is the first hyperscaler to report, so its capex language sets the tone for Alphabet, Microsoft and Amazon next week, as well as chip names.

6. Intuitive Surgical (ISRG) | Beat-and-Dump | Closed $438.00 (+1.11%)

A $450 Million Settlement Turns a 25% EPS Beat Into an 11% After-Hours Drop

Catalyst & latest news: Intuitive posted adjusted EPS of $3.00 versus $2.64 expected on $3.05B of revenue, up 21.7%. But a $450M pre-tax antitrust settlement cut GAAP EPS to $1.49 from $1.95, and shares fell as much as 11% to 13% after hours.

Technicals: ISRG closed at $438.00 near its $440.40 high, then traded between about $378.50 and $406 after hours, versus a 52-week high of $603.88.

Fundamentals: The company now guides 2026 da Vinci procedure growth of 14% to 15% (from 13.5% to 15.5%) and gross margin of 68.7% to 69.3%. GAAP operating margin fell to 19.4% from 30.3%, per Investing.com’s transcript summary. It repurchased $2.9B of stock at an average $377.

MetricData
Last close / prior close$438.00 (+$4.82, +1.11%) / $433.18
Regular-session high$440.40
After-hoursAbout $378.50 – $406 (-7% to -13%)
52-week rangeUp to $603.88 high; low n/v
Market capAbout $166B (derived)
P/E (TTM) / Dividend50.2 (5-year median 70.5) / None
Volume vs. averagen/v
Q3 EPS (adj. / GAAP)$3.00 vs. $2.64 est. / $1.49 vs. $1.95
Revenue$3.05B (+21.7%) vs. $2.91B est.
Cash / buybacks$6.80B / $2.9B in Q3 at an average $377
Analystsn/v (GuruFocus fair value $635.52)
Support (S1 / S2 / S3)$405.99 / $392 / $378.50
Resistance (R1 / R2 / R3)$433.18 / $438.00 / $440.40

Scenarios: Bullish: a quick recovery of $433 as dip buyers step in. Base: an open near $395 to $410 and basing. Bearish: a break of $378.50 opens the $377 buyback zone and below.

Bull case: Strong procedure growth, a $6.8B cash pile and a P/E well below its five-year median. Bear case: Margin compression, a one-time settlement and a stock far below its high.

What to watch:

  • The opening gap against the $378.50 after-hours low
  • Analyst target changes on Wednesday
  • Procedure growth and tariff or pricing commentary

Forecast: Holding $378.50 allows a rebound toward $405 to $433. A break there signals a deeper reset.

Why this matters: Intuitive shows how a beat can still sell off when margins shrink, a theme that also hit Netflix and GM this week.

7. General Motors (GM) | Worst Day in 15 Months | Closed $76.56 (-7.48%)

A $20 Billion Buyback, a Dividend Hike and Still a 7.5% Drop

Catalyst & latest news: GM beat Q3 estimates with revenue of $50.02B versus $48.70B expected and raised its free cash flow outlook, but it narrowed its 2026 profit guidance and the stock fell 7.5%, its worst session in 15 months. CNBC noted guidance sat just below consensus.

Technicals: GM closed at $76.56, down $6.19 from $82.75, and printed around $75.79 intraday. It is roughly 16% below its prior high, which implies about $91.

Fundamentals: Adjusted EBIT guidance is $14.5B to $15.5B (from $14B to $16B), and adjusted EPS guidance is $12.75 to $13.75 against a $13.41 consensus midpoint. The $20B buyback is about 28% to 30% of market value, and the quarterly dividend rose 20% to $0.18.

MetricData
Last close / prior close$76.56 (-$6.19, -7.48%) / $82.75
Day’s rangen/v (intraday low about $75.79)
52-week rangeHigh about $91 (implied); low n/v
Market capAbout $67B (derived)
P/E / DividendAbout 5.8x guided EPS midpoint (derived) / $0.72 a year (about 0.9%)
Volume vs. averagen/v
PerformanceYTD about -5% (premarket reading)
Q3 revenue / adj. EBIT$50.02B (+2.9%) / $4.11B (+21.6%)
Q3 net income / EPS$3.34B / $3.73 (vs. $1.35)
FY26 guidanceAdj. EBIT $14.5B – $15.5B; FCF $11.5B – $12.5B (from $9.5B – $11.5B)
AnalystsBuy (21); average target about $97 – $104; low $75
Support (S1 / S2 / S3)$75.79 / $72 / $65
Resistance (R1 / R2 / R3)$76.82 / $80 / $82.75

Scenarios: Bullish: buyback buyers reclaim $80. Base: a bounce-and-chop between $75 and $79. Bearish: a loss of $75 targets $72.

Bull case: A 5.8x forward multiple, a huge buyback and rising cash flow. Bear case: Slowing sales, rising costs and implied Q4 profit near last year’s level.

What to watch:

  • Whether buyback demand holds the $75 area
  • Analyst target trims on Wednesday
  • Ford and Stellantis read-through

Forecast: Holding $75 keeps a bounce toward $80 plausible. A break likely tests $72.

Why this matters: GM shows how guidance matters more than headline beats, and it is the first big automaker test before Tesla reports.

8. Inovio Pharmaceuticals (INO) | FDA Decision in 10 Days | Close About $1.01

A Micro-Cap Biotech Counting Down to Its First-Ever Approval Date, Oct. 30

Catalyst & latest news: The FDA’s target action date for INO-3107, Inovio’s treatment for recurrent respiratory papillomatosis, is Oct. 30. It has Breakthrough and Orphan designations, and its BLA was accepted in December 2025. Benzinga lists an after-hours price of $1.09, up about 7.9%, which implies a regular close near $1.01. Zacks cut the stock to Hold on Oct. 14.

Technicals: INO closed at $0.99 on Oct. 16 (down 4.8%) and traded near $1.01 on Oct. 20. It sits about 63% below its $2.72 high and just under the $1.10 exercise price of recent warrants.

Fundamentals & financing: Inovio held $36.7M of cash at the end of Q2 and then raised $20M at $0.95 a share with two warrants per share at $1.10, extending its runway to late Q1 2027. Q2’s loss of $0.07 beat the Street.

.
MetricData
Last close (derived) / Oct. 16 closeAbout $1.01 / $0.99 (-4.8%)
After-hours$1.08 – $1.09 (+7% to +7.9%)
52-week range$0.56 – $2.72
Market capAbout $95M (derived; $103M at $1.09)
P/E / Dividendn/a (loss-making) / None
Volume vs. averagen/v
PerformanceAbout -63% from the 52-week high
Cash / runway$36.7M (Q2) plus $20M raise; runway to late Q1 2027
AnalystsZacks Hold; consensus target $3.17; Piper Sandler Buy, $4
Key dateOct. 30 PDUFA for INO-3107
Support (S1 / S2 / S3)$0.99 / $0.95 / $0.85
Resistance (R1 / R2 / R3)$1.09 / $1.15 / $1.27

Scenarios: Bullish: a close above $1.10 into the PDUFA date targets $1.27 or higher. Base: a $0.95 to $1.10 run-up trade. Bearish: a loss of $0.95 sends the stock to the mid-$0.80s.

Bull case: A first commercial product, a $3.17 consensus target and an approval pathway with two special designations. Bear case: An FDA delay or complete response would crush the stock, and warrants near $1.10 cap rallies.

What to watch:
  • Any FDA label or inspection news before Oct. 30
  • Whether $1.10 turns into support
  • Competitor headlines in the same disease

Forecast: A hold above $0.99 keeps an event run-up toward $1.15 to $1.27 alive. A break below $0.95 points to $0.85.

Why this matters: INO is a binary regulatory bet with a date. Approval would validate its DNA-medicine platform, but a rejection could threaten its cash runway.

9. Netcapital (NCPL) | SEC-Charged Small Cap | Close About $2.02 (derived)

Up Almost 30% Intraday, With an SEC Case, a Missing Audit and a Friday Compliance Clock

Catalyst & latest news: NCPL rose 29.9% to $2.12 intraday and traded at $2.19 after hours (+8.4%), which implies a regular close near $2.02. On Oct. 14 the company said it regained Nasdaq’s $1 bid-price compliance, but it remains delinquent on its annual and quarterly reports and must submit a compliance plan by Oct. 23.

Technicals: NCPL swung from about $0.21 in August to a $2.66 high in early October. Tickeron notes $2.50 to $2.66 as the next breakout zone and $2.00 as a round-number pivot.

Fundamentals & red flags: The SEC charged the company with allegedly overstating about $14M of revenue, its auditor and a board member resigned, and class actions followed. Quarterly revenue was about $51K and cash is tiny, so dilution risk is extreme.

MetricData
Last close (derived) / prior close (derived)About $2.02 / about $1.63
Intraday high / after-hours$2.12 / $2.19 – $2.25 (+8.4% to +11.4%)
52-week rangeAbout $0.21 – $2.66
Market capAbout $12M
P/E / Dividendn/a (loss-making) / None
Volume vs. averagen/v (tens of millions on recent days)
Revenue (latest quarter)About $51K vs. $170K a year earlier
LiquidityCurrent ratio about 0.3; cash under $2M
AnalystsNo meaningful coverage; one tracked target about $0.20; Weiss Sell
Key datesOct. 23 Nasdaq compliance plan deadline
Support (S1 / S2 / S3)$1.63 / $1.59 / $1.00
Resistance (R1 / R2 / R3)$2.12 / $2.50 / $2.66

Scenarios: Bullish: a break of $2.12 targets $2.50 to $2.66. Base: wide $1.60 to $2.25 swings. Bearish: a loss of $1.59 erases the regained-compliance rally.

Bull case: Heavy retail momentum, regained bid compliance and a very small float. Bear case: Alleged accounting fraud, an auditor exit, unreliable past financials and possible delisting if reports remain late.

What to watch:
  • The Oct. 23 compliance-plan filing
  • Any new SEC or class-action headlines
  • A dilutive share sale after the spike

Forecast: A close above $2.12 could run to $2.50. A loss of $1.59 likely sends the stock back toward $1.00.

Why this matters: NCPL is a pure momentum trade with serious governance flags. We include it to show how violent these moves are, not as a recommendation.

10. Chaince Digital (CD) | Fintech Rebound | Last Verified Close $6.99 (Oct. 19); Oct. 20 Print About $8.49 (+21.5%)

A $770 Million Fintech That Swung Between $5.26 and $11.18 in One Day

Catalyst & latest news: CD jumped 21.5% to $8.49 intraday on Tuesday during a broad financials small-cap rally. We found no company release on Oct. 20. Recent news includes a discounted equity raise used to buy Sentinel, brokerage mandates of up to $300M and a $2.0M warrant buyback.

Technicals: Marketchameleon shows a Monday close of $6.99 on 280K shares versus a 261K average, a 30-day implied volatility of 148.7% and a 1-day-move range of $5.99 to $7.87. On Oct. 9 CD traded from $5.26 to $11.18.

Fundamentals: Chaince (formerly Mercurity Fintech) offers brokerage, advisory and digital-asset services, plus AI and liquid-cooling infrastructure plans. GuruFocus’ fair value was $8.98 in early October, and Seeking Alpha rates the stock Sell.

MetricData
Last verified close / Oct. 20 print$6.99 (+0.9%, Oct. 19) / about $8.49 (+21.5%, intraday; close n/v)
Oct. 9 range$5.26 – $11.18
52-week range$2.10 – $32.24
Market cap$768.9M at $6.99 (about $0.93B at $8.49, derived)
P/E / DividendAbout -141 / None
Volume vs. average280K vs. 261K – 267K (Oct. 19)
Implied volatility (30-day)148.7%
Fair value / ratingGF Value $8.98; Seeking Alpha Sell
Insider activity$0.3M sold, no purchases in 12 months
Analystsn/v
Support (S1 / S2 / S3)$6.99 / $5.99 / $5.26
Resistance (R1 / R2 / R3)$8.49 / $10.91 / $11.18

Scenarios: Bullish: a hold above $8.49 targets $10.91. Base: a fade back toward $7. Bearish: a loss of $6.99 sends it to $5.99.

Bull case: Growing brokerage mandates, an AI infrastructure angle and a stock far below its high. Bear case: Dilution, thin operations (about 13 employees), a rich valuation and extreme volatility.

What to watch:
  • The Oct. 20 final close and follow-through
  • New financing or Sentinel updates
  • Sales-agent deals such as Top Wealth Group’s $200M offering

Forecast: A hold above $8.49 can reach $10.91. Below $6.99, expect $5.99.

Why this matters: CD is a high-volatility fintech that trades on financing headlines, so verify its closing price before acting.

Sector Sentiment Snapshot and Forecast
GroupNamesSentimentDriver
Mega-cap tech earningsMETA, TSLA, SPCXEvent-drivenCapex returns, AI revenue, margins
AI hardwareSMCIStrong$4B guidance raise
Streaming and consumerNFLXWeakAd forecast cut, slowest growth in three years
Medical devicesISRGFragileOne-time charge, margin pressure
AutosGMPressuredNarrowed guidance, slowing sales
Micro-cap biotech and fintechINO, NCPL, CDSpeculativeFDA date, compliance, financing

Sector forecast: Wednesday’s key test is whether Meta and Tesla can stabilize the AI trade after the Nasdaq’s worst week since June. Options imply moves of about 5.9% for Meta and 6.2% for Tesla, a potential swing of over $100 billion in combined market value. A Super Micro and SpaceX rebound would support AI hardware, but a hot print on rates or oil would hit growth names again. Small caps rallied 1.65% on Tuesday, so expect the same rotation to be tested. For recent micro-cap setups, see TNN’s Oct. 12 penny stocks under $3 and Oct. 13 top 10 stocks.

Stocks to Watch Tomorrow: At a Glance
#StockLast CloseMoveCatalystKey SupportKey Resistance
1SPCX$147.79-0.11% (AH +1.5% to +5%)Q3 beat, 161% revenue growth$140$155.40
2SMCI$32.47+1.15% (AH +12% to +15%)Q1 guidance raised $4B$32.10$35.09
3NFLX$68.69-1.66% (AH about -5.8%)Ad forecast cut$64.62$68.69
4TSLA$373.71+1.54%Earnings after close$363.64$375.45
5META$694.25-1.59%Earnings after close$681.05$705.44
6ISRG$438.00+1.11% (AH -7% to -13%)Settlement, margin concerns$405.99$433.18
7GM$76.56-7.48%Narrowed guidance$75.79$76.82
8INOAbout $1.01n/v (AH about +7.9%)Oct. 30 FDA date$0.99$1.09
9NCPLAbout $2.02About +24% (derived)Compliance plan due Oct. 23$1.63$2.12
10CD$6.99 (Oct. 19)About +21.5% Oct. 20Fintech rebound$6.99$8.49

Follow TNN for daily stock market news and financial news today.

Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment, or legal advice. All market investments carry inherent risks of capital loss, and small-cap, micro-cap, event-driven and high-volatility stocks carry elevated risk, including dilution, delisting and total loss. Stock prices, percentage moves, and market data cited reflect figures available at the time of publication and are subject to change as trading continues. After-hours prices are indicative and some closes are derived or unverified and labeled as such. Reports of regulatory actions and legal claims are allegations. Support and resistance levels are analytical zones, not predictions. Analyst price targets and ratings are third-party estimates and do not guarantee actual results. Always complete independent due diligence prior to executing equity trades.

About The Author